The Beiruter
drug development
-
drug development - Neurotechnology - Orexin - GLP-1 - narcolepsyCould the next GLP-1 target the brain?
A new class of drugs targeting the brain’s orexin system is beginning with narcolepsy, but its potential across attention, mood and neurological disease has prompted comparisons with the extraordinary expansion of GLP-1 medicines.By The Beiruter
